Report Detail
Global Emerging Infectious Disease Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4694947 |
- 11 May, 2026 |
- Global |
- 118 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Emerging Infectious Disease market size was valued at US$ 23470 million in 2025 and is forecast to a readjusted size of US$ 34590 million by 2032 with a CAGR of 5.8% during review period.
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
The global emerging infectious disease market refers to the market for diagnostics, treatments, and preventive measures for newly discovered or re-emerging infectious diseases. Emerging infectious diseases are those that have recently appeared in a population or have existed but are rapidly increasing in incidence or geographic range. These diseases pose a significant public health threat and require innovative approaches for detection, management, and control.
Here are some key factors influencing the growth of the global emerging infectious disease market:
Outbreaks and epidemics: The occurrence of outbreaks and epidemics of emerging infectious diseases, such as Ebola, Zika virus, and COVID-19, has created a heightened global awareness of the need for robust diagnostic tools, therapeutics, and preventive measures. These outbreaks drive the demand for rapid and accurate diagnostics to identify the causative agents, along with effective treatments and preventive strategies to control the spread of the diseases.
Technological advancements: Advances in diagnostic technologies, including nucleic acid amplification techniques, immunoassays, and point-of-care diagnostics, have significantly improved the speed and accuracy of diagnosing emerging infectious diseases. Additionally, the development of new antiviral drugs, vaccines, and other therapeutics has expanded treatment options for these diseases. The integration of technologies such as artificial intelligence, genomics, and big data analytics further enhances the capabilities of the healthcare system in managing emerging infectious diseases.
Government initiatives and funding: Governments and international organizations have recognized the need to invest in research and development, surveillance systems, and infrastructure to effectively respond to emerging infectious diseases. Increased funding and initiatives aimed at strengthening healthcare systems, surveillance networks, and research collaborations drive innovations in diagnostics, therapeutics, and preventive measures.
Global travel and urbanization: Increased global travel and urbanization contribute to the spread and emergence of infectious diseases. The movement of people across borders allows infections to spread rapidly, making it crucial to have effective measures in place for detection, containment, and treatment. This drives the demand for improved diagnostics, therapeutics, and public health strategies targeting emerging infectious diseases.
Antimicrobial resistance: The rise of antimicrobial resistance poses a significant challenge in the management of emerging infectious diseases. The limited effectiveness of existing antibiotics and antiviral drugs necessitates the development of new treatment options, including novel antibiotics, combination therapies, and innovative strategies that target the resistance mechanisms of pathogens.
The global emerging infectious disease market can be segmented based on disease type, diagnostic methods, treatment modalities, and geography. Disease types may include viral, bacterial, parasitic, and others. Diagnostic methods can include molecular diagnostics, immunoassays, and rapid diagnostic tests. Treatment modalities may include antiviral drugs, antibiotics, vaccines, and supportive care.
Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of different emerging infectious diseases, healthcare infrastructure, and government initiatives may vary across these regions.
In summary, the global emerging infectious disease market is driven by outbreaks and epidemics, technological advancements, government initiatives, global travel, and antimicrobial resistance. Key players in the market are focused on developing innovative solutions for diagnostics, treatments, and preventive measures. The market is expected to witness significant growth as the need for effective management of emerging infectious diseases continues to rise globally.
This report is a detailed and comprehensive analysis for global Emerging Infectious Disease market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Emerging Infectious Disease market size and forecasts, in consumption value ($ Million), 2021-2032
Global Emerging Infectious Disease market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Emerging Infectious Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Emerging Infectious Disease market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Emerging Infectious Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Emerging Infectious Disease market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, Roche Diagnostics, Merck & Co., Inc., GlaxoSmithKline plc, BioMerieux, Danaher, Orasure, Qiagen, Quidel, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Emerging Infectious Disease market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
Market segment by Application
Clinical Laboratories
Diagnostic Centers
Others
Market segment by players, this report covers
BD
Abbott
Roche Diagnostics
Merck & Co., Inc.
GlaxoSmithKline plc
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Emerging Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Emerging Infectious Disease, with revenue, gross margin, and global market share of Emerging Infectious Disease from 2021 to 2026.
Chapter 3, the Emerging Infectious Disease competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Emerging Infectious Disease market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Emerging Infectious Disease.
Chapter 13, to describe Emerging Infectious Disease research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Emerging Infectious Disease by Type
- 1.3.1 Overview: Global Emerging Infectious Disease Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Emerging Infectious Disease Consumption Value Market Share by Type in 2025
- 1.3.3 AIDS
- 1.3.4 Ebola
- 1.3.5 SARS
- 1.3.6 Avian Flu
- 1.3.7 Chikungunya
- 1.3.8 Zika
- 1.3.9 Others
- 1.4 Global Emerging Infectious Disease Market by Application
- 1.4.1 Overview: Global Emerging Infectious Disease Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Clinical Laboratories
- 1.4.3 Diagnostic Centers
- 1.4.4 Others
- 1.5 Global Emerging Infectious Disease Market Size & Forecast
- 1.6 Global Emerging Infectious Disease Market Size and Forecast by Region
- 1.6.1 Global Emerging Infectious Disease Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Emerging Infectious Disease Market Size by Region, (2021-2032)
- 1.6.3 North America Emerging Infectious Disease Market Size and Prospect (2021-2032)
- 1.6.4 Europe Emerging Infectious Disease Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Emerging Infectious Disease Market Size and Prospect (2021-2032)
- 1.6.6 South America Emerging Infectious Disease Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Emerging Infectious Disease Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 BD
- 2.1.1 BD Details
- 2.1.2 BD Major Business
- 2.1.3 BD Emerging Infectious Disease Product and Solutions
- 2.1.4 BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 BD Recent Developments and Future Plans
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Emerging Infectious Disease Product and Solutions
- 2.2.4 Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Abbott Recent Developments and Future Plans
- 2.3 Roche Diagnostics
- 2.3.1 Roche Diagnostics Details
- 2.3.2 Roche Diagnostics Major Business
- 2.3.3 Roche Diagnostics Emerging Infectious Disease Product and Solutions
- 2.3.4 Roche Diagnostics Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Roche Diagnostics Recent Developments and Future Plans
- 2.4 Merck & Co., Inc.
- 2.4.1 Merck & Co., Inc. Details
- 2.4.2 Merck & Co., Inc. Major Business
- 2.4.3 Merck & Co., Inc. Emerging Infectious Disease Product and Solutions
- 2.4.4 Merck & Co., Inc. Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Merck & Co., Inc. Recent Developments and Future Plans
- 2.5 GlaxoSmithKline plc
- 2.5.1 GlaxoSmithKline plc Details
- 2.5.2 GlaxoSmithKline plc Major Business
- 2.5.3 GlaxoSmithKline plc Emerging Infectious Disease Product and Solutions
- 2.5.4 GlaxoSmithKline plc Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 GlaxoSmithKline plc Recent Developments and Future Plans
- 2.6 BioMerieux
- 2.6.1 BioMerieux Details
- 2.6.2 BioMerieux Major Business
- 2.6.3 BioMerieux Emerging Infectious Disease Product and Solutions
- 2.6.4 BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 BioMerieux Recent Developments and Future Plans
- 2.7 Danaher
- 2.7.1 Danaher Details
- 2.7.2 Danaher Major Business
- 2.7.3 Danaher Emerging Infectious Disease Product and Solutions
- 2.7.4 Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Danaher Recent Developments and Future Plans
- 2.8 Orasure
- 2.8.1 Orasure Details
- 2.8.2 Orasure Major Business
- 2.8.3 Orasure Emerging Infectious Disease Product and Solutions
- 2.8.4 Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Orasure Recent Developments and Future Plans
- 2.9 Qiagen
- 2.9.1 Qiagen Details
- 2.9.2 Qiagen Major Business
- 2.9.3 Qiagen Emerging Infectious Disease Product and Solutions
- 2.9.4 Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Qiagen Recent Developments and Future Plans
- 2.10 Quidel
- 2.10.1 Quidel Details
- 2.10.2 Quidel Major Business
- 2.10.3 Quidel Emerging Infectious Disease Product and Solutions
- 2.10.4 Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Quidel Recent Developments and Future Plans
- 2.11 Sysmex
- 2.11.1 Sysmex Details
- 2.11.2 Sysmex Major Business
- 2.11.3 Sysmex Emerging Infectious Disease Product and Solutions
- 2.11.4 Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Sysmex Recent Developments and Future Plans
- 2.12 Gen-Probe
- 2.12.1 Gen-Probe Details
- 2.12.2 Gen-Probe Major Business
- 2.12.3 Gen-Probe Emerging Infectious Disease Product and Solutions
- 2.12.4 Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Gen-Probe Recent Developments and Future Plans
- 2.13 Cepheid
- 2.13.1 Cepheid Details
- 2.13.2 Cepheid Major Business
- 2.13.3 Cepheid Emerging Infectious Disease Product and Solutions
- 2.13.4 Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Cepheid Recent Developments and Future Plans
- 2.14 Hologic
- 2.14.1 Hologic Details
- 2.14.2 Hologic Major Business
- 2.14.3 Hologic Emerging Infectious Disease Product and Solutions
- 2.14.4 Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Hologic Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Emerging Infectious Disease Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Emerging Infectious Disease by Company Revenue
- 3.2.2 Top 3 Emerging Infectious Disease Players Market Share in 2025
- 3.2.3 Top 6 Emerging Infectious Disease Players Market Share in 2025
- 3.3 Emerging Infectious Disease Market: Overall Company Footprint Analysis
- 3.3.1 Emerging Infectious Disease Market: Region Footprint
- 3.3.2 Emerging Infectious Disease Market: Company Product Type Footprint
- 3.3.3 Emerging Infectious Disease Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Emerging Infectious Disease Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Emerging Infectious Disease Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Emerging Infectious Disease Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Emerging Infectious Disease Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Emerging Infectious Disease Consumption Value by Type (2021-2032)
- 6.2 North America Emerging Infectious Disease Market Size by Application (2021-2032)
- 6.3 North America Emerging Infectious Disease Market Size by Country
- 6.3.1 North America Emerging Infectious Disease Consumption Value by Country (2021-2032)
- 6.3.2 United States Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 6.3.3 Canada Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Emerging Infectious Disease Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Emerging Infectious Disease Consumption Value by Type (2021-2032)
- 7.2 Europe Emerging Infectious Disease Consumption Value by Application (2021-2032)
- 7.3 Europe Emerging Infectious Disease Market Size by Country
- 7.3.1 Europe Emerging Infectious Disease Consumption Value by Country (2021-2032)
- 7.3.2 Germany Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 7.3.3 France Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 7.3.5 Russia Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 7.3.6 Italy Emerging Infectious Disease Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Emerging Infectious Disease Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Emerging Infectious Disease Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Emerging Infectious Disease Market Size by Region
- 8.3.1 Asia-Pacific Emerging Infectious Disease Consumption Value by Region (2021-2032)
- 8.3.2 China Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 8.3.3 Japan Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 8.3.5 India Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 8.3.7 Australia Emerging Infectious Disease Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Emerging Infectious Disease Consumption Value by Type (2021-2032)
- 9.2 South America Emerging Infectious Disease Consumption Value by Application (2021-2032)
- 9.3 South America Emerging Infectious Disease Market Size by Country
- 9.3.1 South America Emerging Infectious Disease Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Emerging Infectious Disease Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Emerging Infectious Disease Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Emerging Infectious Disease Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Emerging Infectious Disease Market Size by Country
- 10.3.1 Middle East & Africa Emerging Infectious Disease Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Emerging Infectious Disease Market Size and Forecast (2021-2032)
- 10.3.4 UAE Emerging Infectious Disease Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Emerging Infectious Disease Market Drivers
- 11.2 Emerging Infectious Disease Market Restraints
- 11.3 Emerging Infectious Disease Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Emerging Infectious Disease Industry Chain
- 12.2 Emerging Infectious Disease Upstream Analysis
- 12.3 Emerging Infectious Disease Midstream Analysis
- 12.4 Emerging Infectious Disease Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Emerging Infectious Disease. Industry analysis & Market Report on Emerging Infectious Disease is a syndicated market report, published as Global Emerging Infectious Disease Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Emerging Infectious Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
